The federal government has entered into two agreements to secure millions of doses of potential COVID-19 vaccines.
Public Services and Procurement Minister Anita Anand announced that the Government of Canada has entered into agreements with Pfizer and Moderna. Pfizer will provide its mRNA-based vaccine candidate BNT162, while Moderna will provide its mRNA-1273 vaccine candidate.
All potential vaccines will require regulatory approval from Health Canada before they can be used to immunize Canadians.
Public Services and Procurement Canada also purchases the equipment and supplies needed to manufacture and produce the vaccine in Canada, as well as other supplies to ensure safe immunization, such as syringes, alcohol swabs and gauze.
At a press conference in Toronto with Minister of Science and Industry Navdeep Bains, Anand said today’s announcement marked “an important step forward.” The agreements will ensure that Canadians are “on the front lines” when a vaccine is approved.
Developing a vaccine normally takes years, if not decades, but scientific teams around the world aim to develop a vaccine for the coronavirus that causes COVID-19 in 12 to 18 months.
As active negotiations with other potential vaccine suppliers are underway, the government cannot disclose details of the contract, according to a press release.